Little Green Pharma Ltd (ASX: LGP) has received its first shipment of cannabis flower medicines in Australia from its recently acquired Danish Facility.
The shipment comprises ~50kgs of LGP’s “LGP Flower THC 16 – Billy Buttons” flower medicine, named after the eponymous Australian wildflower.
Billy Buttons THC 16 has a THC content of 16% and is available in the Australian market in 15g packs. LGP’s Billy Buttons medicine is grown under Good Agricultural and Collection Practices (GACP), manufactured under EU Good Manufacturing Practices (EU GMP), and conforms with Therapeutic Goods (TGO 93) Order 2017.
The company was able to successfully import the shipment in just over two months following its acquisition of the Facility.
LGP’s Billy Buttons THC 16 medicine is now available for sale in Australia through all pharmacies. LGP anticipates two further shipments of LGP cannabis flower medicines (totalling ~65kgs) from the Facility arriving by end October 2021.
Dried flower medicine sales in Australia have seen an increase in demand as doctors become more comfortable with this method of administration, with cannabis flower frequently prescribed due to its rapid onset of therapeutic benefit.
Key appointments
In addition, the company has made two key appointments, Morten Snede as Chief Financial Officer and Tony Roberts as the Group’s General Manager (EU).
Mr Snede brings more than 20 years of experience from various senior level managerial positions in the financial and maritime industries as both a CFO and Group Director.
In 2018 he joined Canopy Growth as Managing Director (Denmark) tasked with the establishment and development of the Facility. Mr Snede has also been on several Boards within the Maritime industry as well as being Chairman of the Board of the Medical Cannabis Industry Association in Denmark.
He holds a MSc in Commercial law and Business administration and a Service Engineering degree from his time in the Danish Royal Navy. He also has a Postgraduate diploma in International and Maritime Law from the London Metropolitan University.
Mr Roberts was previously the Managing Director of Tasmanian Botanics Pty Ltd for 3.5 years, during which time he established one of the first fully integrated seed to sale, TGA-GMP certified, medicinal cannabis facilities engaged in cultivation, genetic research and manufacturing in Australia and capable of producing substantial quantities of dry biomass.
Prior to this, he was an independent business consultant for over 10 years in Australia and overseas, working with businesses in strategic planning, corporate governance, product development and organisational design; and before he had over 34 years’ experience in an Australian ASX listed agribusiness, with 20 years as a senior corporate executive involved in financial services, business acquisition, strategic planning, IT design and implementation and customer development. Mr Roberts has also acted as a Chairman and Director of various companies and community organisations and is a Member of the Institute of Credit Management and a Justice of the Peace.
